B16-OVA melanoma cells express the OVA antigen, which is recognized by OT-I (CD8+) T cells isolated from OT-I mice (48, 49), making it a relevant model to study tumor-specific CD8+ T cell responses. The gene discussed is CD8A; the disease is neoplasm.